These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 24247052)

  • 1. When do psychiatric side effects emerge during antiviral treatment of hepatitis C?
    Gazdag G; Horváth G; Szabó O; Takács R; Ungvari GS
    Psychiatr Danub; 2013 Dec; 25(4):398-400. PubMed ID: 24247052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
    Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
    Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of peg-Interferon and Ribavirin combined antiviral treatment in a Romanian hepatitis C virus infected cohort.
    Predescu O; Streba LA; Irimia E; Streba L; Mogoantă L
    Rom J Morphol Embryol; 2012; 53(3):497-502. PubMed ID: 23010773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric symptoms during interferon treatment for hepatitis C: experiences from a tertiary care hepatology centre.
    Evon DM; Verma A; Simpson K; Galanko JA; Dougherty KA; Fried MW
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1071-80. PubMed ID: 18266996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
    Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
    Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of chronic hepatitis C: side effects, tolerability and quality of life].
    Gournay J; Richou C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B60-75. PubMed ID: 12180310
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis.
    Hosoda S; Takimura H; Shibayama M; Kanamura H; Ikeda K; Kumada H
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):565-72. PubMed ID: 11043807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of HCV treatment in patients with inherited bleeding disorders.
    Fransen van de Putte DE; Fischer K; Posthouwer D; Mauser-Bunschoten EP
    Haemophilia; 2011 Sep; 17(5):791-9. PubMed ID: 21689211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of psychiatric diagnosis on treatment uptake and interferon side effects in patients with hepatitis C.
    Wu JY; Shadbolt B; Teoh N; Blunn A; To C; Rodriguez-Morales I; Chitturi S; Kaye G; Rodrigo K; Farrell G
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1258-64. PubMed ID: 24955454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.
    Pariante CM; Landau S; Carpiniello B;
    N Engl J Med; 2002 Jul; 347(2):148-9. PubMed ID: 12110753
    [No Abstract]   [Full Text] [Related]  

  • 12. An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C.
    Tinè F; Graviano D; Giannuoli G; Madonia S; Malizia G; Patti S; Fasola S; Cottone M; D'Amico G;
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1113-23. PubMed ID: 20848397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.
    Quelhas R; Lopes A
    J Psychiatr Pract; 2009 Jul; 15(4):262-81. PubMed ID: 19625882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of depression and somatic symptoms in patients on interferon alpha/ribavirin for chronic hepatitis C.
    Shakoor A; Shafqat F; Mehmud Te; Akram M; Riaz S; Iqbal Z; Khan AA
    J Ayub Med Coll Abbottabad; 2010; 22(4):6-9. PubMed ID: 22455250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depressive disorders and symptoms accompanying pegylated interferon alpha and ribavirin treatment of chronic hepatitis C patients].
    Pawełczyk T; Białkowska J; Jabłkowski M; Pawełczyk A; Strzelecki D; Rabe-Jabłońska J; Dworniak D
    Pol Merkur Lekarski; 2008 Jun; 24(144):516-20. PubMed ID: 18702333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

  • 19. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C.
    Tavakoli-Tabasi S; Bagree A
    J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
    Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
    Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.